Effects of cross-sex hormone therapy on metabolism and eating behavior
Official title: Investigation of the Effects of Testosterone and Estrogen on Eating Behavior, Metabolism, Energy Balance and Cardiovascular System in Transsexual Patients Undergoing Cross-sex Hormone Therapy
Run by University of Leipzig · NCT04838249 · Data updated 2026-11-12
This study looks at how cross-sex hormone therapy affects metabolism, eating habits, and overall health in people undergoing this treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 80 (estimated) |
| Sponsor | University of Leipzig Academic / other |
| Locations | 1 site (Leipzig, Saxony) |
| Status | Recruiting |
| Started | May 5, 2021 |
| Main results expected | May 2026 |
| Study ends | May 2026 |
| Registry record updated | December 5, 2025 |
| Trial ID | NCT04838249 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are transsexual patients undergoing cross-sex hormone therapy who are weight stable and have a BMI of 30 kg/m2 or less.
✕Probably not a fit
Patients with severe medical impairments or those who have self-initiated cross-sex hormone therapy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the interconnected physiological systems in patients undergoing cross-sex hormone therapy, focusing on glucose and lipid metabolism, energy balance, eating behavior, and cardiovascular health. It seeks to gather insights into how sex hormones influence these systems and their potential role in overeating, obesity, insulin resistance, and cardiovascular disease. Additionally, the study will investigate the relationships between gut and oral microbiomes and their impact on these physiological systems.
Why it matters
Potential benefit: If successful, this study could provide valuable insights into the health impacts of cross-sex hormone therapy, potentially improving treatment strategies for transgender individuals.
How similar studies have gone: While there is limited data on the specific effects of cross-sex hormone therapy on these physiological systems, similar studies have shown promising results in understanding hormonal impacts on metabolism and cardiovascular health.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * transsexual patients undergoing cross-sex hormone therapy versus controls * able to give informed consent, if \<18 years from all legal guardians * only for part B (patients will participate in all other study parts): weight stable (± 5%) for last 3 months, BMI ≤ 30 kg/m2 Exclusion Criteria: * severe medical impairments (e.g., uncontrolled cardiovascular disease, severe heart failure, uncontrolled hypertension, cerebral insult, active malign disease, etc.) * self-initiated cross-sex hormone therapy before study start only for part B (patients will participate in all other study parts): Insufficiently controlled endocrine disorders (Cushing's disease, other uncontrolled pituitary disorders, uncontrolled hypothyroidism, hyperthyroidism, etc.) * Chronic pulmonary disorders, including chronic obstructive pulmonary disease that would limit ability to follow the protocol (investigator judgment) and obstructive sleep apnea syndrome; only subjects with mild or exercise-induced asthma on no medications or on beta-adrenergic agonists only will be allowed to enter the study (provided use of these agents is not required for 1 week before * Diagnosed gastrointestinal diseases, including inflammatory bowel diseases (e.g. Crohn's disease and ulcerative colitis), malabsorption syndromes (e.g. celiac disease), gastric ulcer (active); only subjects with gastro-esophageal reflux will be allowed to enter the study entry). * History of HIV infection or ongoing chronic infection (such as tuberculosis) * only for part D (patients will participate in all other study parts): Contraindication against performance of an MRI scan (i.e., presence of metal in body, tattoos in head/neck region, claustrophobia etc.)
Where it's running
-
Helmholtz Institute for Metabolic, Obesity and Vascular Research
Leipzig, Saxony, Germany Recruiting
Study contacts
- Study coordinator: Haiko Schloegl, MD
- Email: haiko.schloegl@medizin.uni-leipzig.de
- Phone: 004934197
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sleep and arterial function in hypertensive patients with poor sleep quality
This trial tests whether using cognitive-behavioural therapy for insomnia can improve artery health and well-being in adults with high blood pressure and poor sleep.
-
Can mouth health and chewing help explain arterial stiffness in healthy adults
This study tests whether a profile of oral health and function adds information about central arterial stiffness beyond traditional risk factors in healthy adults.
-
Somatic and Psychological Profile of Athletes Across Seasonal Cycles
This study tests how body composition, eating behaviors, perfectionism, and body image change in team-sport athletes across different seasons.
-
Genotype-based versus standard dietary counseling to reduce weight and body fat.
This test sees if dietary advice based on your genes helps Greek adults with overweight lose more weight and reduce body fat compared with standard dietary advice.
-
Insulin delivery technology and eating behaviours in people with type 1 diabetes
This project will test whether automated insulin delivery systems change eating behaviours and make carbohydrate counting easier for people aged 12 and older who have type 1 diabetes in Canada.
-
How Lipoprotein(a) affects artery stiffness, blood vessel lining, and heart muscle movement
This project will see if higher Lipoprotein(a) levels are linked to stiffer arteries, worse endothelial function, and changes in left atrial and left ventricular motion in adults 18–75.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.